Videos
Femtech in the Spotlight — An Interview with Wolfgang Hackl — Founder and CEO of OncoGenomX
July 11, 2022
Eva von Mühlenen (Advisor, Geneva) and Josefine Sommer (Senior Managing Associate, Brussels) interviewed Wolfgang Hackl, founder of OncoGenomX, a Femtech startup that guides doctors in the treatment of breast cancer — about regulation, research and development (R&D), and the vast potential of artificial intelligence in the field of health technology for women.
Contacts
Related Resources
Related Blogs
Capabilities
Related Pages
Suggested News & Insights
Sidley Sponsors the 2026 EU Pharma Law ForumTuesday, May 19, 2026 – Thursday, May 21, 2026Inside Strategic Partnerships: Clinical Trial Considerations and AI/Digital Health InsightsThursday, March 12, 2026Generative AI and Privilege: Practical Lessons from Two Early Decisions and What Comes NextFebruary 27, 2026Sidley Represents Precision NeuroMed in Its Strategic Partnership With Brainlab SEFebruary 27, 2026TX AG’s Office Continues Aggressive Enforcement Against Healthcare Entities Operating in TexasFebruary 25, 2026New York LLC Transparency Act Took Effect January 1, 2026; U.S.-Formed LLCs Exempt from Reporting ObligationsFebruary 25, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory